1. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation. 1998. 37:2099–2100.
2. Terry RB, Page WF, Haskell WL. Waist-hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a twenty-three year follow up study. Int J Obes Relat Metab Disord. 1992. 16:417–423.
3. Tracy RP. Inflammation in cardiovascular disease; cart, horse, or both? Circulation. 1998. 97:2000–2002.
4. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002. 105:804–809.
5. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002. 22:147–152.
6. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis. J Am Coll Cardiol. 2002. 40:521–528.
7. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, et al. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta 2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol. 1999. 34:2007–2014.
8. Suh HS, Park YW, Kang JH, Lee SH, Lee HS, Shim KW. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women. Int J Obes (Lond). 2005. 29:217–222.
9. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, et al. Abdominal body fat distribution detected by computed tomography in diabetic men. Invest Radiol. 1986. 21:483–487.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assesment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985. 28:412–419.
11. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/NO pathway on beta-adrenergic mediated vasodilation in human forearm vasculature. Circulation. 1997. 95:2293–2297.
12. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989. 80:1652–1659.
13. Seger P, Qasem A, DeBacker T, Carlier S, Verdonck P, Avolio A. Peripheral 'oscillatory' compliance is associated with aortic augmentation index. Hypertension. 2001. 37:1434–1439.
14. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM. 2002. 95:67–74.
15. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord. 1999. 23:936–942.
16. Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord. 1998. 22:477–484.
17. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000. 49:883–888.
18. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000. 101:948–954.
19. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med. 2004. 140:992–1000.
20. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992. 340:1430–1432.
21. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994. 24:471–476.
22. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, et al. Estrogen improves endothelium-dependent, flow mediated vasodilation in postmenopausal women. Ann Intern Med. 1994. 121:936–941.
23. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 1996. 28:573–579.
24. Vogel RA, Corretti MC, Plotnick GD. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol. 1996. 77:37–40.
25. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997. 95:1126–1131.
26. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 1998. 98:1158–1163.
27. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation. 1998. 97:1234–1238.
28. Gill JM, Al-Mamari A, Ferrell WR, Cleland SJ, Packard CJ, Sattar N, et al. Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol. 2004. 21:2375–2382.
29. Anderson TJ, Uehata A, Gerhard MD, Meredith IT. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995. 26:1235–1241.
30. Hope SA, Tay DB, Meredith IT, Cameron JD. Use of arterial transfer functions for the derivation of arterial wave form characteristics. J Hypertens. 2003. 21:1299–1305.
31. Lemogoum D, Flores G, Van den Abeele W, Ciarka A, Leeman M, Degaute JP. Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens. 2004. 22:511–517.
32. Williams B. Pulse wave analysis and hypertension: evangelism versus skepticism. J Hypertens. 2004. 22:447–449.